industry

Regeneron Pharmaceuticals, Inc. stands as a prominent player in the biopharmaceutical industry, with a strong strategic focus on novel therapeutic areas. The company’s financial performance is robust, with a market capitalization of $103.43 billion, showcasing a substantial industry presence. Additionally, Regeneron’s earnings per share (EPS) have shown an upward trajectory, with projections indicating continued growth.
0 Comments
British newspaper groups have reacted strongly to Apple’s plans to introduce a “web eraser” tool that would block advertisements in the Safari browser. They have highlighted the potential threat this tool poses to the financial sustainability of journalism. The removal of ads or unwanted website content could significantly impact digital revenues in the industry, which
0 Comments
Jane Schoenbrun’s film, I Saw Then TV Glow, has seen a significant increase in box office earnings in its second week, with an estimated $195k+ on 21 screens. This expansion marks a successful rollout, driven by a passionate fan base particularly among young, male, and LGBTQ+ audiences. The gender-bending supernatural thriller is set to continue
0 Comments
Moderna announced on Friday that the Food and Drug Administration has postponed the approval of its respiratory syncytial virus (RSV) vaccine to the end of May due to what they described as “administrative constraints” within the agency. The decision, which was anticipated to be made on Sunday, has left investors on edge as they await
0 Comments
Semiconductor Manufacturing International Corporation (SMIC) recently issued a profit warning after its first-quarter earnings fell short of expectations. The company cited intense competition in the chip industry as a primary reason for the decline in profits. According to SMIC, the pricing for commodity products is heavily influenced by market trends, making it challenging for the
0 Comments
Singapore’s Oversea-Chinese Banking Corp (OCBC) has recently reported a 5% increase in first-quarter profit, exceeding market expectations. In a bold move, the bank has also made a S$1.4 billion ($1.04 billion) offer to acquire its insurer arm Great Eastern, showcasing its commitment to strategic investments and portfolio enhancement. The offer, which includes a 37% premium
0 Comments
The Consumer Financial Protection Bureau’s regulation aimed at reducing late fees on credit cards is facing significant opposition from the card industry, led by the U.S. Chamber of Commerce. The industry sued the CFPB in federal court in an attempt to block the implementation of the new rule, which would cap late fees at $8
0 Comments